We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-21.52%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$82.4M
AUM Growth
-$25.7M
Cap. Flow
-$1.74M
Cap. Flow %
-2.11%
Top 10 Hldgs %
93.72%
Holding
33
New
4
Increased
11
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
KALA icon
KALA BIO
KALA
+$9.07M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.78M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$1.51M
4
ICMB icon
Investcorp Credit Management BDC
ICMB
+$1.04M
5
GARS
Garrison Capital Inc.
GARS
+$798K

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$1.03M
2
UHAL icon
U-Haul Holding Co
UHAL
+$963K
3
JBGS
JBG SMITH
JBGS
+$707K
4
LITS
Lite Strategy Inc
LITS
+$677K
5
CPRX
Catalyst Pharmaceutical
CPRX
+$276K

Sector Composition

Rank Sector Weight
1 Healthcare 68.7%
2 Financials 10.95%
3 Real Estate 0.94%
4 Technology 0.32%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CACC icon
26
Credit Acceptance
CACC
$6.69B
– –
-459
Closed -$201K
CPRX
27
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-72,967
Closed -$276K
PCG icon
28
PG&E
PCG
$38.1B
– –
-22,500
Closed -$1.03M
SPY icon
29
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-51,279
Closed -$14.9M
UHAL icon
30
U-Haul Holding Co
UHAL
$13.9B
– –
-27,000
Closed -$963K
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-3,178
Closed -$222K
SRRA
32
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-2,797
Closed -$190K
FPAC.U
33
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
– –
-23,030
Closed -$237K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2018 Portfolio in Review

As of Q4 2018, Caxton Corporation held 33 positions worth $82.4M, down 24% from $108M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Caxton Corporation's Q4 2018 filing shows 4 new, 11 increased, 8 reduced and 8 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,010 shares worth $3.5M. The largest sale was PG&E, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 60% a quarter earlier, followed by Financials and Real Estate.

  • Caxton Corporation's largest Q4 2018 buy was State Street SPDR S&P 500 ETF Trust: 14,010 shares worth $3.5M.
  • Caxton Corporation added most to KALA BIO in Q4 2018, an estimated $9.07M increase.
  • Caxton Corporation's biggest Q4 2018 reduction was JBG SMITH, cutting an estimated $707K.
  • Caxton Corporation fully exited PG&E in Q4 2018, selling an estimated $1.03M.
  • Caxton Corporation's ten largest holdings make up 94% of its $82.4M portfolio in Q4 2018.
  • Caxton Corporation opened 4 new positions and closed 8 in Q4 2018.
  • Caxton Corporation's portfolio value fell 24% quarter-over-quarter to $82.4M.

Based on Caxton Corporation's 13F filing for Q4 2018, filed 14 Feb 2019.